Prostate Cancer Risk Groups
Have You Determined Your Risk Group?
Prostate Cancer Risk Group is the most common way that doctors battling prostate cancer use to classify the cancer and its progression. Each risk group identifies the current state of the cancer at the cell level, the aggressiveness of the cancer, the progression of the cancer within the prostate, outside the prostate, to other organs or to distant parts of the body. Treatment options become clearer for the patient, once the prostate cancer risk group is understood. For patients classified as Low Risk, the cancer has been discovered early, which allows for many successful treatment options. For patients classified as Intermediate or High Risk, the cancer has progressed, treatment decisions become more complicated and combinations of treatments maybe recommended to increase the odds for a successful outcome.
Prostate Cancer Risk Group is the most common way that doctors battling prostate cancer use to classify the cancer and its progression. Each risk group identifies the current state of the cancer at the cell level, the aggressiveness of the cancer, the progression of the cancer within the prostate, outside the prostate, to other organs or to distant parts of the body. Treatment options become clearer for the patient, once the prostate cancer risk group is understood. For patients classified as Low Risk, the cancer has been discovered early, which allows for many successful treatment options. For patients classified as Intermediate or High Risk, the cancer has progressed, treatment decisions become more complicated and combinations of treatments maybe recommended to increase the odds for a successful outcome.
What Three Things Determine Your Risk Group?
Your Prostate Specific Antigen or PSA
Your Prostate Cancer Stage
Your Gleason Score
Is Your Prostate Cancer Risk Group: Low, Intermediate or High?
Compare Prostate Cancer Treatments
Treatment outcomes show how many patients remain prostate cancer free, and for how many years following treatment. These comparisons are done by patient Risk Group. Patients with prostate cancer that has been detected early, fall into the low risk group. Those with more advanced cancer will fall into intermediate or high risk groups of prostate cancer.
Compare Treatments by Selecting Risk Group
Low Risk
PSA less than 10
and
Gleason Score less than 7
and
Clinical Stage is T1c to T2a
Intermediate Risk
PSA greater than 10 less than 20
or
Gleason Score is 7
or
Clinical Stage is T2b
High Risk
PSA greater than 20
or
Gleason Score is 8 to 10
or
Clinical Stage is T2c to T3c
LEARN TO FIGHT PROSTATE CANCER.
Top Ten Steps - Fight Prostate Cancer
Learn the Top Ten Steps, a guide through knowledge about the prostate, prostate cancer, diagnosis and treatment. Watch our video, introducing Edward Weber, MD. and hear his advice to men just diagnosed with prostate cancer. Get expert advice for your fight against Prostate Cancer.
Remission versus Recurrence?
Relapse of prostate cancer is way more common than you might think. Many men treated for prostate cancer have their cancer return, recurrence, which can lead to a lifetime of treatment. Prostate Cancer Free studies treatment outcomes. The STUDY, updated for 2021, is available to print or download. Relapse is determined by periodic monitoring PSA Levels in the blood. No relapse or remaining in remission for 10-15 years after prostate cancer treatment, makes it very unlikely that the cancer will ever return. Complete remission, no more treatment.
Help To Continue the Work!
The Prostate Cancer Free Foundation, reviews the results of hundreds of thousands of men treated for prostate cancer. Tracking them for years. This information is available to you, and others like you, to help find the best prostate cancer treatment. This work takes time, effort, resources all of it done by volunteers. Please help us continue. Please Donate!